The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
34
No.
27
July 11, 2008
- Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.
- National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.
- President Signs Supplemental Funding For NIH And FDA.
- FDA To Issue “Complete Response” Letters To Drug Sponsors.
- PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.
TCL
Vol.
34
No.
28
July 18, 2008
CCL
Vol.
31
No.
7
July 25, 2008
- VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds
- Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence
- Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women
- Gene Therapy Shows Positive Results In Phase III Trial
- New Genetic Test Approved For Breast Cancer Patients
- NCI Cooperative Group, Cancer Center Trials Listed
TCL
Vol.
34
No.
30
August 01, 2008
- Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.
- Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.
- Believers “Flout Fundamental Law Of Physics,” Park Says.
- Davis Denies “Cherry-Picking” Data To Support Her Claims.
- ACS President Huerta Disagrees With Staff On Cell Phone Danger.
CCL
Vol.
31
No.
8
August 29, 2008
- Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
- Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
- Quality Of Care Varies Widely For Prostate Cancer, Study Says
- Prostatectomy Improves Outcome In Some Men
- Risk of Relapse Continues After Five Years of Therapy
- Two Breast Cancer Screening Methods Found Equivalent
- Zometa Prevents Bone Loss In Premenopausal Women
- Risk Assessment Key In Long-Term Treatment
- Survey Finds Misconceptions About Cancer Worldwide
- NCI Cooperative Group, Cancer Center Trials Listed